73 related articles for article (PubMed ID: 11087203)
1. Preconception immunization with a cytomegalovirus (CMV) glycoprotein vaccine improves pregnancy outcome in a guinea pig model of congenital CMV infection.
Bourne N; Schleiss MR; Bravo FJ; Bernstein DI
J Infect Dis; 2001 Jan; 183(1):59-64. PubMed ID: 11087203
[TBL] [Abstract][Full Text] [Related]
2. Glycoprotein B (gB) vaccines adjuvanted with AS01 or AS02 protect female guinea pigs against cytomegalovirus (CMV) viremia and offspring mortality in a CMV-challenge model.
Schleiss MR; Choi KY; Anderson J; Mash JG; Wettendorff M; Mossman S; Van Damme M
Vaccine; 2014 May; 32(23):2756-62. PubMed ID: 23867012
[TBL] [Abstract][Full Text] [Related]
3. Animal Models of Congenital Cytomegalovirus Transmission: Implications for Vaccine Development.
Roark HK; Jenks JA; Permar SR; Schleiss MR
J Infect Dis; 2020 Mar; 221(Suppl 1):S60-S73. PubMed ID: 32134481
[TBL] [Abstract][Full Text] [Related]
4. The Placental Response to Guinea Pig Cytomegalovirus Depends Upon the Timing of Maternal Infection.
Berkebile ZW; Putri DS; Abrahante JE; Seelig DM; Schleiss MR; Bierle CJ
Front Immunol; 2021; 12():686415. PubMed ID: 34211475
[TBL] [Abstract][Full Text] [Related]
5. Progress toward Development of a Vaccine against Congenital Cytomegalovirus Infection.
Schleiss MR; Permar SR; Plotkin SA
Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046308
[TBL] [Abstract][Full Text] [Related]
6. Modeling of vertical transmission and pathogenesis of cytomegalovirus in pregnancy: Opportunities and challenges.
Kirschen GW; Burd I
Front Virol; 2023; 3():. PubMed ID: 36908829
[TBL] [Abstract][Full Text] [Related]
7. Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization.
Nelson CS; Jenks JA; Pardi N; Goodwin M; Roark H; Edwards W; McLellan JS; Pollara J; Weissman D; Permar SR
J Virol; 2020 Apr; 94(9):. PubMed ID: 32051265
[TBL] [Abstract][Full Text] [Related]
8. A fifty-year odyssey: prospects for a cytomegalovirus vaccine in transplant and congenital infection.
Diamond DJ; La Rosa C; Chiuppesi F; Contreras H; Dadwal S; Wussow F; Bautista S; Nakamura R; Zaia JA
Expert Rev Vaccines; 2018 Oct; 17(10):889-911. PubMed ID: 30246580
[TBL] [Abstract][Full Text] [Related]
9. Maternal Immunity and the Natural History of Congenital Human Cytomegalovirus Infection.
Britt WJ
Viruses; 2018 Aug; 10(8):. PubMed ID: 30081449
[TBL] [Abstract][Full Text] [Related]
10. Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys.
Nelson CS; Cruz DV; Tran D; Bialas KM; Stamper L; Wu H; Gilbert M; Blair R; Alvarez X; Itell H; Chen M; Deshpande A; Chiuppesi F; Wussow F; Diamond DJ; Vandergrift N; Walter MR; Barry PA; Cohen-Wolkowiez M; Koelle K; Kaur A; Permar SR
JCI Insight; 2017 Jul; 2(13):. PubMed ID: 28679960
[TBL] [Abstract][Full Text] [Related]
11. Congenital Cytomegalovirus: a "Now" Problem-No Really, Now.
Bernstein DI
Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27795304
[TBL] [Abstract][Full Text] [Related]
12. Maternal vaccination: moving the science forward.
Faucette AN; Unger BL; Gonik B; Chen K
Hum Reprod Update; 2015; 21(1):119-35. PubMed ID: 25015234
[TBL] [Abstract][Full Text] [Related]
13. A neutralizing anti-gH/gL monoclonal antibody is protective in the guinea pig model of congenital CMV infection.
Auerbach MR; Yan D; Vij R; Hongo JA; Nakamura G; Vernes JM; Meng YG; Lein S; Chan P; Ross J; Carano R; Deng R; Lewin-Koh N; Xu M; Feierbach B
PLoS Pathog; 2014 Apr; 10(4):e1004060. PubMed ID: 24722349
[TBL] [Abstract][Full Text] [Related]
14. Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?
Schleiss MR
Future Virol; 2013 Dec; 8(12):1161-1182. PubMed ID: 24523827
[TBL] [Abstract][Full Text] [Related]
15. Guinea Pig Cytomegalovirus (GPCMV): A Model for the Study of the Prevention and Treatment of Maternal-Fetal Transmission.
Schleiss MR; McVoy MA
Future Virol; 2010 Mar; 5(2):207-217. PubMed ID: 23308078
[TBL] [Abstract][Full Text] [Related]
16. Intravaginal cytomegalovirus (CMV) challenge elicits maternal viremia and results in congenital transmission in a guinea pig model.
Olejniczak MJ; Choi KY; McVoy MA; Cui X; Schleiss MR
Virol J; 2011 Mar; 8():89. PubMed ID: 21371319
[TBL] [Abstract][Full Text] [Related]
17. Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention.
Cheeran MC; Lokensgard JR; Schleiss MR
Clin Microbiol Rev; 2009 Jan; 22(1):99-126, Table of Contents. PubMed ID: 19136436
[TBL] [Abstract][Full Text] [Related]
18. Immunobiology of human cytomegalovirus: from bench to bedside.
Crough T; Khanna R
Clin Microbiol Rev; 2009 Jan; 22(1):76-98, Table of Contents. PubMed ID: 19136435
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the nucleotide sequence of the guinea pig cytomegalovirus (GPCMV) genome.
Schleiss MR; McGregor A; Choi KY; Date SV; Cui X; McVoy MA
Virol J; 2008 Nov; 5():139. PubMed ID: 19014498
[TBL] [Abstract][Full Text] [Related]
20. Cellular and humoral immune responses to alphavirus replicon vaccines expressing cytomegalovirus pp65, IE1, and gB proteins.
Reap EA; Dryga SA; Morris J; Rivers B; Norberg PK; Olmsted RA; Chulay JD
Clin Vaccine Immunol; 2007 Jun; 14(6):748-55. PubMed ID: 17442845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
